Back to Atlas
BSemi-durableStandard research/education caution
CMP-0185
Endogenous / research
C-peptide
Metabolic / Vascular
May have microvascular and neuropathy-relevant effects in insulin-deficient states
Reading this compound Reference only
Information below is educational. Dosing, mechanisms and status fields are compiled from the source list at the bottom of this page — always verify against a licensed clinician before use.
Reference-only summary of publicly discussed or source-listed patterns. Not medical advice and not a personal recommendation.
Mechanism & Use
- Compound type
- Peptide hormone fragment
- Primary mechanism
- Insulin propeptide with proposed renal, vascular, and microvascular signaling roles
- Primary market use
- Diabetes physiology
Pharmacology
- Molecular weight (Da)
- ~3,020
- Oral bioavailability
- N/A (peptide; not oral)
- Half-life
- ~30-35 min
- Route tags
- SubQ; Injectable; route-dependent
- Evidence level
- Human/Clinical physiology
- Clinical status
- Endogenous / research
- Value-for-money score
- 4 / 10
Reported protocol signal
No clean popular protocol found in uploaded sources; create as research/reference entry and verify before public protocol display.
For orientation only. See disclaimer — always consult a licensed clinician before use.
Notes
Potential value is context-dependent; strongest rationale in C-peptide deficiency rather than general enhancement